Search
There were a total of 27 results for your search.
Pirbright scientists show gene editing tool could crack down on diseases spread by southern house mosquitoes
A new gene editing tool has been successfully applied to the southern house mosquito by researchers at The Pirbright Institute. This paves the way for genetic control methods that could prevent the...
Type: News
Key mutations in Alpha variant enable SARS-CoV-2 to overcome evolutionary weak points
One of the key mutations seen in the ‘Alpha variant’ of SARS-CoV-2 – the deletion of two amino acids, H69/V70 – enables the virus to overcome chinks in its armour as it evolves, say an international...
Type: News
Pirbright pig studies indicate human antibody could provide protection from flu
Studies undertaken at The Pirbright Institute in collaboration with Inovio Pharmaceuticals have shown that a human antibody (2-12C) can provide pigs protection against the 2009 H1N1 pandemic strain...
Type: Press release
Pigs as universal flu vaccine models
Researchers from The Pirbright Institute collaborated with the University of Oxford and the National Institutes of Health, USA, to show that S-FLU, a universal flu vaccine candidate, induces...
Type: Press release
Pirbright research to boost vaccine production
Scientists at The Pirbright Institute have received money which will enable research into boosting vaccine yields by up to ten fold. The funding was awarded by the Livestock Vaccine Innovation Fund...
Type: Press release
Pirbright Annual Report showcases investment in innovation
The Pirbright Institute’s Annual Report 2019-2020 showcases a year of scientific progress in the world of viral diseases. The COVID-19 pandemic has thrown into sharp focus the importance of the...
Type: Press release
Our governance
The Pirbright Institute is an independent company, limited by guarantee and a registered charity, governed by a Board of non-executive Trustee Directors. Research at the Institute is reviewed by an...
Type: Page
Pages
- « first
- ‹ previous
- 1
- 2
- 3 of 3